SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso(San Francisco General Hospital), Bryan Greenhouse(University of California, San Francisco), Timothy J. Henrich(University of California, San Francisco), Jeffrey N. Martin(University of California, San Francisco), Matthew A. Spinelli(University of California, San Francisco), Joanna Donatelli(University of California, San Francisco), Monica Gandhi(University of California, San Francisco), Jeffrey I. Cohen(National Institutes of Health), Mary-Ann Palafox(Abbott Fund), Xin Zhou(Shandong Provincial Hospital), Rebecca Hoh(University of California, San Francisco), Mary A. Rodgers(Discovery Laboratories (United States)), Terri Wrin, Saki Takahashi(Hyogo Medical University), Susanna K. Elledge(Massachusetts Institute of Technology), Charles Y. Chiu(University of California, San Francisco), Peter D. Burbelo(National Institutes of Health), John C. Prostko(Abbott Fund), Christos J. Petropoulos(IGM Biosciences (United States)), Viva Tai(University of California, San Francisco), Isabel Rodríguez-Barraquer(University of California, San Francisco), Keirstinne Turcios(University of California, San Francisco), Nikita S. Iyer(University of California, San Francisco), Philip J. Norris(University of California, San Francisco), Emily A. Fehrman(University of California, San Francisco), Mars Stone(Pacific Research Institute), John E. Pak(Chan Zuckerberg Initiative (United States)), James A. Wells(University of California, San Francisco), Rachel L. Rutishauser(Johns Hopkins University), Cassandra Thanh(University of California, San Francisco), Jill Hakim(University of California, San Francisco), Michael P. Busch(Vitalant), Steven G. Deeks(University of California, San Francisco), Leonel Torres(University of California, San Francisco), J. Daniel Kelly(University of California, San Francisco), Wesley Wu(Chan Zuckerberg Initiative (United States)), Yanel Hernandez(University of California, San Francisco), Ana Vallari(Abbott Fund), Theodore W. Kurtz(University of California, San Francisco), John Hackett(Abbott Fund), Clara DiGermanio(Pacific Research Institute), Lan Trinh, Christopher C. Nixon(University of California, San Francisco), Albert C. Shu(University of California, San Francisco), Sadie E. Munter(University of California, San Francisco), Owen Janson(University of California, San Francisco)
Cited by 150
Related Papers
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
|Circulation|2005|4k
CRISPR–Cas12-based detection of SARS-CoV-2
|Nature Biotechnology|2020|2.8k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
|Hypertension|2004|2.1k